Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Authors:
- 31 October 2006
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 109 (5) , 2183-2189
Abstract
Nasal NK/T-cell lymphoma is a rare disease entity with a poor outcome. Expression of antiapoptotic proteins has not been extensively investigated in this entity. Forty-eight patients with nasal T/NK-cell lymphoma who received first-line polychemotherapy (n = 44) or chemoradiotherapy (n = 4) were analyzed for expression of active caspase-3 (aC3), granzyme B protease inhibitor 9 (PI9), and Bcl-2 proteins. Lymphomas were CD3+/CD5−/granzyme B+ and EBV-associated. Median age was 46 years. Stage I/II disease was present in 75% of the cases and an International Prognostic Index (IPI) score less than 1 in 65%. With a median follow-up of 6.3 years, 5-year event-free survival (EFS) and overall survival (OS) rates were 39% and 49%, respectively. Apoptotic index was scored as high in 32% of cases and PI9 expression as positive in 68%, whereas 35% disclosed a high number of aC3+ tumor cells. Univariate analysis showed that absence of PI9 and low apoptotic index were associated with poor outcome, but not aC3 expression nor IPI score. By multivariate analysis, both parameters affected independently EFS (P = .02 and .08, respectively) and OS (P = .009 and .04). In view of its constitutive expression by normal NK cells, it is suggested that loss of PI9 expression in tumor cells may reflect some mechanism associated with progression.Keywords
This publication has 64 references indexed in Scilit:
- Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell LymphomaJournal of Clinical Oncology, 2006
- Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal typeBlood, 2005
- Radiation therapy versus chemotherapy as initial treatmentfor localized nasal natural killer (NK)/T-cell lymphoma:a single institute survey in TaiwanAnnals of Oncology, 2004
- Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphomaCancer, 2004
- Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic IndexBlood, 2004
- Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modalityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynxLeukemia, 2001
- Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patientsClinical and Laboratory Haematology, 2000
- Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation TreatmentJournal of Clinical Oncology, 2000
- Anticancer Drugs Induce Caspase-8/FLICE Activation and Apoptosis in the Absence of CD95 Receptor/Ligand InteractionBlood, 1999